Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors.

被引：0

作者：

Kuo, GH ^{[1
]}

Wang, AH ^{[1
]}

Emanuel, S ^{[1
]}

DeAngelis, A ^{[1
]}

Zhang, R ^{[1
]}

Connolly, PJ ^{[1
]}

Murray, WV ^{[1
]}

Gruninger, RH ^{[1
]}

Sechler, J ^{[1
]}

Fuentes-Pesquera, A ^{[1
]}

Johnson, D ^{[1
]}

Middleton, SA ^{[1
]}

Jolliffe, L ^{[1
]}

Chen, X ^{[1
]}

机构：

[1] Johnson & Johnson Pharmaceut Res, Drug Discovery Div, Raritan, NJ 08869 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 228卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

233-MEDI

引用

页码：U950 / U950

页数：1

共 50 条

[1] Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 inhibitors
Kuo, GH
Wang, AH
Emanuel, S
DeAngelis, A
Zhang, R
Connolly, PJ
Murray, WV
Gruninger, RH
Sechler, J
Fuentes-Pesquera, A
Johnson, D
Middleton, SA
Jolliffe, L
Chen, X
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 1886 - 1900
[2] Synthesis and structure-activity relationships of pyrazine-pyridine biheteroaryls as novel, potent and selective vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors.
Kuo, GH
Prouty, C
Wang, AH
Emanuel, S
DeAngelis, A
Zhang, Y
Song, FB
Connolly, PJ
Karnachi, P
Chen, X
Gruninger, RH
Sechler, J
Angel, FP
Middleton, SA
Jolliffe, L
Murray, WV
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U129 - U129
[3] Synthesis and structure-activity relationships of pyrazine-pyridine biheteroaryls as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors
Kuo, GH
Prouty, C
Wang, AH
Emanuel, S
DeAngelis, A
Zhang, Y
Song, FB
Beall, L
Connolly, PJ
Karnachi, P
Chen, X
Gruninger, RH
Sechler, J
Fuentes-Pesquera, A
Middleton, SA
Jolliffe, L
Murray, WV
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) : 4892 - 4909
[4] Discovery of Potent Vascular Endothelial Growth Factor Receptor-2 Inhibitors
Papakyriakou, Athanasios
Katsarou, Maria E.
Belimezi, Maria
Karpusas, Michael
Vourloumis, Dionisios
CHEMMEDCHEM, 2010, 5 (01) : 118 - 129
[5] Discovery of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors by Ligand-based Virtual High Throughput Screening
Chelliah, Selvam
Mock, Charlotta D.
Mathew, Omana P.
Ranganna, Kasturi
FASEB JOURNAL, 2018, 32 (01):
[6] Anti-angiogenic Agents: A Review on Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors
Cheng, Kang
Liu, Chen-Fu
Rao, Guo-Wu
CURRENT MEDICINAL CHEMISTRY, 2021, 28 (13) : 2540 - 2564
[7] Discovery of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors by Ligand-based Virtual High Throughput Screening
Selvam, Chelliah
Mock, Charlotta D.
Mathew, Omana P.
Ranganna, Kasturi
Thilagavathi, Ramasamy
MOLECULAR INFORMATICS, 2020, 39 (07)
[8] Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity
Alam, A
Herault, JP
Barron, P
Favier, B
Fons, P
Delesque-Touchard, N
Senegas, I
Laboudie, P
Bonnin, J
Cassan, C
Savi, P
Ruggeri, B
Carmeliet, P
Bono, FO
Herbert, JM
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 324 (02) : 909 - 915
[9] In-silico screening and In-vitro validation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) inhibitors
Saraswat, Deepika
Nehra, Sarita
Chaudhary, Kamal Kumar
Prasad, C. V. S. Siva
BIOINFORMATION, 2014, 10 (05) : 273 - 280
[10] Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity
Al-Hussain, Sami A.
Farghaly, Thoraya A.
Zaki, Magdi E. A.
Abdulwahab, Hanan G.
Al-Qurashi, Nadia T.
Muhammad, Zeinab A.
BIOORGANIC CHEMISTRY, 2020, 105

← 1 2 3 4 5 →